Literature DB >> 2519344

The uses and limitations of calmodulin antagonists.

M L Veigl1, R E Klevit, W D Sedwick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2519344     DOI： 10.1016/0163-7258(89)90066-1

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  9 in total

1.  Role of Ca2+ and protein kinase C in the receptor-mediated activation of Na+/H+ exchange in isolated liver cells.

Authors:  A Martín-Requero; F J Daza; O G Hermida; N Butta; R Parrilla
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Characteristics of nitric oxide-mediated cholinergic modulation of calcium current in rabbit sino-atrial node.

Authors:  X Han; L Kobzik; D Severson; Y Shimoni
Journal:  J Physiol       Date:  1998-06-15       Impact factor: 5.182

3.  Suramin and the suramin analogue NF307 discriminate among calmodulin-binding sites.

Authors:  M Klinger; E Bofill-Cardona; B Mayer; C Nanoff; M Freissmuth; M Hohenegger
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

4.  The effects of uranyl ions on neuromuscular transmission in the urinary bladder of the normal and streptozotocin-diabetic mouse.

Authors:  S H Liu; S Y Lin-Shiau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

5.  Regulation of the receptor for platelet-activating factor on human platelets.

Authors:  J A Burgers; J W Akkerman
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

Review 6.  Putative therapeutic applications of calmodulin antagonists.

Authors:  R Mannhold; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

7.  Attenuation of calmodulin regulation evokes Ca2+ oscillations: evidence for the involvement of intracellular arachidonate-activated channels and connexons.

Authors:  Egor A Turovsky; Valery P Zinchenko; Nikolai P Kaimachnikov
Journal:  Mol Cell Biochem       Date:  2019-02-11       Impact factor: 3.396

8.  Grb7-derived calmodulin-binding peptides inhibit proliferation, migration and invasiveness of tumor cells while they enhance attachment to the substrate.

Authors:  Juan Alcalde; María González-Muñoz; Antonio Villalobo
Journal:  Heliyon       Date:  2020-05-07

9.  Dynamics and structural changes of calmodulin upon interaction with the antagonist calmidazolium.

Authors:  Corentin Léger; Irène Pitard; Mirko Sadi; Nicolas Carvalho; Sébastien Brier; Ariel Mechaly; Dorothée Raoux-Barbot; Maryline Davi; Sylviane Hoos; Patrick Weber; Patrice Vachette; Dominique Durand; Ahmed Haouz; J Iñaki Guijarro; Daniel Ladant; Alexandre Chenal
Journal:  BMC Biol       Date:  2022-08-09       Impact factor: 7.364
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.